Current Market Information

Last Trade Price (LTP) 143.00 Updated Date 21 November, 2024 Change 0.00 % Open Price 143.00 Day's Range 143.00 - 143.00     Total Trade 0 Total Volume 0 Close Price 0 Previous Close Price 143.00 Market Capital in BDT (mn) 33033.000

Contact Information

Designation Name Mobile Number Email Chairman Mrs. Nurun Nahar Karim 01913397900 nkarim@beaconpharma.com.bd MD Mr. Mohammad Ebadul Karim 01713240344 ebadul@beaconpharma.com.bd CFO Mr. Md. Abdul Haque Sarder, FCS FCA 01713156222 sarder@beacongroup.com.bd Company Secretary Mr. Md. Sahabuddin FCS 01713156477 sahabuddin@beaconpharma.com.bd Office Address Beacon Business Centre 9/B/2, Toyenbee Circular Road, Motijheel, Dhaka-1213 Phone : 02-57165371-76 Fax : 02-57165379 Email : beacon@beaconpharma.com.bd Website : http://www.beaconpharma.com.bd Factory Address Beacon Pharmaceuticals Limited,Khathali, Bhaluka, Mymemsingh

Basic Information

Authorized Capital in BDT* (mn) 3,000.00 Paid-up Capital in BDT* (mn) 2,310.00 Face Value 10 Paid up Share 231000000     Market Lot 1 Sector PHARMA & CHEMICALS Market Category A

Other Information

Listing Year 2010 Debut Trade Date 12 August, 2010 Type of Instrument     52 Week's Range 111.00 - 279.10 Year End 30 June Reserve / Surplus(mn) 3780.39 Remarks Tk 890,880,677 Revaluation Surplus has been added to Reserve & Surplus. Note

Share Holding Percentage

Sponsor/Director Govt. Institute Foreign Public As on 31-Oct, 2024 39.863 0 38.838 0 21.299 As on 30-Sep, 2024 39.863 0 38.898 0 21.239 As on 31-Aug, 2024 39.863 0 38.736 0 21.401 As on 30-Jun, 2024 (year ended) 39.863 0 39.07 0 21.067     Remarks Note     Credit Rating Status Credit Rating Year Long Term Short Term Outlook Validity Date Credit Rating Company Nov 13, 2024 AA3 ST-2 Stable Nov 30, 2025 Credit Rating Agency of Bangladesh Ltd. (CRAB) Nov 15, 2023 AA3 ST-2 Stable Nov 30, 2024 Credit Rating Agency of Bangladesh Ltd. (CRAB) Dec 05, 2022 A1 ST-3 Stable Nov 30, 2023 Credit Rating Agency of Bangladesh Ltd. (CRAB)         Half Year End (HY) Information  202312 HY Net Turnover(mn)  5099.35 HY Net Profit after tax(mn)  751.89 HY EPS  3.25  AGM Information   AGM Date  23 December, 2024 Record Date  27 October, 2024 Dividend(%)  30.00(20% Cash Dividend to General Shareholder and 10% Cash Dividend to Sponsor Shareholder and Directors-June 2024) Bonus Issue  5% 2011

   

Financial Performance
Performance Year	Basic EPS Based On		Basic EPS (restated) Based On		Net Asset Value Per Share	Restated Net Asset Value Per Share	Net Profit After Tax(mn)		% Dividend	% Dividend Yield
	Continuous operations	Including Extra-Ordinary Income	Continuous operations	Including Extra-Ordinary Income			Continuous operations	Including Extra-Ordinary Income
2023	2.21	0	0	0	25.72	0	509.87	0	16%C	0.63
2022	4.05	0	0	0	25.73	0	935.04	0	16%C	0.62
2021	3.74	0	0	0	23.18	0	863.17	0	15%C	1.21
2020	1.65	0	0	0	20.04	0	380.69	0	6%C	0.99
2019	0.51	0	0	0	12.9	0	117.7	0	5%C	2.49

Financial Statements
Quarterly Financial Statement	https://www.beaconpharma.com.bd/financial-statements/
Price Sensitive Information	https://www.beaconpharma.com.bd/price-sensitive-informations/

Close Price and Traded Volume Graph
Click here to view 1 month graph	Click here to view 3 month graph	Click here to view 6 month graph
Form	To